Breast core needle biopsy: Issues and controversies

Modern Pathology

Volumn 23, Issue , 2010, Pages S36-S45

  Bilous, Michael ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Breast; Core needle biopsy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

BLEEDING; BREAST BIOPSY; BREAST CALCIFICATION; BREAST CANCER; BREAST CARCINOMA; BREAST CYST; BREAST FIBROADENOMA; BREAST HYPERPLASIA; BREAST LESION; BREAST PAPILLOMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CORE NEEDLE BIOPSY; DIAGNOSTIC ACCURACY; DRUG DOSE REDUCTION; EXCISION; FLUORESCENCE IN SITU HYBRIDIZATION; GRANULATION TISSUE; HEMATOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION; INFLAMMATION; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAMMOGRAPHY; NEEDLE BIOPSY; PNEUMOTHORAX; PRIORITY JOURNAL; REVIEW; SYNCOPE; VACUUM ASSISTED CORE BIOPSY;

BIOPSY, NEEDLE; BREAST NEOPLASMS; FEMALE; HUMANS; PATHOLOGY, SURGICAL;

EID: 77952003149     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.34     Document Type: Article

References (41)

1. NHSBSP Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening Publication No. 50 June 2001.
2. Stomper PC, Connolly JL, Meyer JE, et al. Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation. Radiology 1989;172:235-241.
3. Consensus conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee. Cancer 1997;80:1798-1802.
4. Jackman RJ, Nowels KW, Shepard MJ, et al. Stereotaxic large-core needle biopsy of 450 non palpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 1994;193: 91-95.
5. Harris GC, Denley HE, Pinder SE, et al. Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma. Am J Surg Pathol 2003;27:11-15.
6. Hoda SA, Harigopal M, Harris GC, et al. Expert opinion: what should be included in reports of needle core biopsies of breast? Histopathol 2003;43:87-90.
7. McIlhenny C, Doughty JC, George WD, et al. Optimum number of core biopsies for accurate assessment of histologic grade in breast cancer. Br J Surg 2002;89:84-85.
8. Rhodes A, Jasani B, Barnes D, et al. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol 2000;53:125-130.
9. Layfield L, Gupta D, Mooney E. Assessment of tissue oestrogen and progesterone receptor levels: a survey of current practice, techniques and quantitation methods. Breast J 2000;6:189-196.
10. Wood B, Junckerstorff R, Sterrett G, et al. A comparison of immunohistochemical staining of oestrogen receptor, progesterone receptor and HER-2 in breast core biopsies and subsequent excisions. Pathology 2007;39:391-395.
11. Jacobs TW, Siziopikou KP, Prioleau JE, et al. Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor? Mod Pathol 1998;11: 259-264.
12. Mann G, Fahey V, Feleppa F, et al. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer. J Clin Oncol 2005;23:5148-5154.
13. Mueller-Holzner E, Fink V, Frede T, et al. Immunohistochemical determination of HER2 expression in breast cancer from core biopsy specimens: a reliable predictor of HER2 status of the whole tumour. Breast Cancer Res Treat 2001;69:13-19.
14. Connor CS, Tawfik AJ, Davis MS, et al. A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical excisions. Am J Surg 2002;184:322-324.
15. Taucher S, Rudas M, Mader RM, et al. Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer. Wien Klin Wochenschr 2004;116:26-31.
16. Burge CN, Chang HR, Apple SK. Do histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens? The Breast 2006;2:167-172.
17. Cavaliere A, Sidoni A, Scheibel M, et al. Biopathologic profile of breast cancer core biopsy: is it always a valid method? Cancer Lett 2005;218:117-121.
18. Lee AHS, Denley HE, Pinder SE, et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathol 2003;42:331-336.
19. Lee AHS, Hodi Z, Ellis IO, et al. Histologic features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast. Histopathol 2007;51:336-344.
20. Jacobs TW, Chen Y-Y, Guinee DG, et al. Fibroepithelial lesions with cellular stroma on breast core needle biopsy; are there predictors of outcome on surgical excision? Am J Clin Pathol 2005;124:342-354.
21. Moore GH, Schiller JE, Moore GK. Radiation-induced histopathologic changes of the breast. The effects of time. Am J Surg Pathol 2004;28:47-53.
22. Kraus FT, Neubecker RD. The differential diagnosis of papillary tumours of the breast. Cancer 1962;15:444-455.
23. Ichihara S, Fujimoto T, Hashimoto K, et al. Double staining with p63 and high molecular weight cytokeratins distinguishes borderline papillary lesions of the breast. Pathol Int 2007;57:126-132.
24. Liberman L, Tornos C, Huzjan R, et al. Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy? Am J Roentgenol 2006;186:1328-1334.
25. Jacobs TW, Connolly JL, Schnitt SJ. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise? Am J Surg Pathol 2002;26:1095-1110.
26. Jacobs TW, Guinee DG, Holden J, et al. Intraductal papillomas without atypia on breast core needle biopsy (CNB): surgical excision is advisable. Mod Pathol 2005;18(Suppl):37A.
27. Valdes EK, Tartter PI, Genelus-Dominique E, et al. Significance of papillary lesions at percutaneous breast biopsy. Ann Surg Oncol 2006;13:480-482.
28. Carter D. Intraductal papillary tumors of the breast. A study of 76 cases. Cancer 1977;39:1689-1692.
29. Fine RE, Boyd BA, Whitworth PW, et al. Percutaneous removal of benign breast masses using a vacuumassisted hand held device with ultrasound guidance. Am J Surg 2002;184:332-336.
30. Mathew J, Crawford DJ, Lwin M, et al. Ultrasoundguided, vacuum-assisted excision in the diagnosis and treatment of clinically benign breast lesions. Ann R Coll Surg Engl 2007;89:494-496.
31. Vargas HI, Vargas MP, Gonzalez K, et al. Percutaneous excisional biopsy of palpable breast masses under ultrasound visualization. Breast J 2006;12(Suppl): S218-S222.
32. Rosen PP, Lesser ML, Kinne DW. Breast carcinoma at the extremes of age: a comparison of patients younger than 35 years and older than 75 years. J Surg Oncol 1985;28:90-96.
33. Rosen PP, Wang T-Y. Colloid carcinoma of the breast. Analysis of 64 patients with long-term follow-up. Am J Clin Pathol 1980;73:30.
34. Hamele-Bena D, Cranor ML, Rosen PP. Mammary mucocoele-like lesions: benign and malignant. Am J Surg Pathol 1996;20:1081-1085.
35. Weaver MG, Abdul-Karim FW, al-Kaisi N. Mucinous lesions of the breast: a pathological continuum. Pathol Res Pract 1993;189:873-876.
36. Brenner RJ, Jackman RJ, Parker SH, et al. Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary? Am J Roentgenol 2002;179: 1179-1184.
37. Sloane JP, Mayers MM. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathol 1993;23:225-231.
38. Diaz LK, Wiley EL, Venta LA. Are malignant cells displaced by large-gauge needle core biopsy of the breast? Am J Roentgenol 1999;173:1303-1313.
39. Boppana S, May M, Hoda S. Does prior fine-needle aspiration cause diagnostic difficulties in histologic evaluation of breast carcinomas? Lab Invest 1994;70:13A.
40. Lee KC, Chan JK, Ho LC. Histologic changes in the breast after fine needle aspiration. Am J Surg Pathol 1994;18:1039-1047.
41. King TA, Ganaraj A, Fey JV, et al. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events. Experience in patients undergoing prophylactic mastectomy. Cancer 2004;101:926-933.